Click here to join the case LOS ANGELES, March 23, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Root, Inc. ("Root" or "the Company") (NASDAQ: ROOT) investors …
AAXLL Brands Company’s Balance CBD is delighted to offer free CBD to persons that can provide proof of their COVID-19 vaccination. San Francisco, March 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- As the U.S. continues to provide COVID-19 vaccinations …
DAVIS, Calif., March 23, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, …
Investors with losses are encouraged to contact the firm before March 29, 2021; click here to submit trade information LOS ANGELES, March 23, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises investors that a class action lawsuit has been filed on …
Both properties are located in Phenix City, Alabama and financing totaled $10,032,000 COLUMBUS, GEORGIA, UNITED STATES, March 23, 2021 /EINPresswire.com/ -- Trillium Capital Resources is pleased to announce the successful closing of two …
Lead program ORIC-101 on track for two initial data readouts in 2021 Three IND/CTA filings for ORIC-533, -944, and -114 expected in 2021 Cash, Cash Equivalents and Investments of $293.6 million expected to fund current operations into second half of …
DAVIS, Calif., March 23, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) has provided its financial results for the fourth quarter and full year ended December 31, 2020. Key results include: Revenues increased 31% in fiscal year 2020, …
MEMPHIS, Tenn., March 23, 2021 (GLOBE NEWSWIRE) -- AutoZone, Inc. (NYSE: AZO), today announced its Board of Directors authorized the repurchase of an additional $1.5 billion of the Company’s common stock in connection with its ongoing share repurchase …
NEWARK, Calif., March 23, 2021 (GLOBE NEWSWIRE) -- ShotSpotter, Inc. (NASDAQ: SSTI), a leader in precision policing technology solutions that enable law enforcement to more effectively respond to, investigate and deter crime, announced today that it will …
- Advanced ALG-010133 and ALG-000184 into the clinic - both expected to generate safety and antiviral activity data in Chronic Hepatitis B (CHB) patients in 2021 - Listed on NASDAQ Global Select Market under the symbol ALGS and raised $167.2 million in …
50% of patients in the Phase 2b CONTROL study have now been randomized despite COVID-19 disruptions in the trial marketplace Cash Position of $10.4 Million at December 31, 2020 BASKING RIDGE, NJ, March 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- …
SANTA MARIA, Calif., March 23, 2021 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Lifecore Biomedical, Inc. and Curation Foods, Inc., will hold a conference call on Wednesday …
Fourth quarter revenue of $677 million and EPS of $0.06 significantly impacted by COVID-19 pandemic Actions to reduce fixed costs and discretionary spending supported profitability for fiscal 2021 while protecting investments to drive future growth …
HOUSTON, March 23, 2021 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced it will report financial results for the fourth quarter and full year …
Third quarter sales of $410 million, down 26% from the prior year reflecting the continued impact of COVID-19 Third quarter GAAP diluted earnings per share from continuing operations of $0.87 Adjusted diluted earnings per share from continuing operations …
NEW YORK, March 23, 2021 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), a health and wellness company, today announced that it will provide a business update and report fourth quarter and full year 2020 financial …
Positive End-of-Phase 2 meeting with the FDA for entospletinib in newly diagnosed NPM1-mutated acute myeloid leukemia First patient dosed in Phase 1/2 trial of KB-0742, an oral CDK9 inhibitor targeting MYC-amplified cancers $462.1 million in cash, cash …
SAN DIEGO and TAICANG, China, March 23, 2021 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (the “Company”), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory …
Completed enrollment of ATYR1923 clinical trial in patients with pulmonary sarcoidosis. Data is expected in the third quarter. Results from ATYR1923 clinical trial in patients with COVID-19 severe respiratory complications demonstrated favorable safety …
Full Year 2020 Total Revenue Growth of 7% Full Year 2020 Net Revenue Growth of 13% Full Year Software and Payments Segment Revenue Growth of 18% Provides Financial Guidance for the Full Year 2021 LAWRENCEVILLE, N.J., March 23, 2021 (GLOBE NEWSWIRE) -- BTRS …
